Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
In a group of patients with PAH treated with treprostinil, the current study aims to
investigate the effect of treatment on RV structure and function; and correlate changes in RV
structure and function with: World Health Organisation (WHO) class, Six-minute walk test,
Quality of life (QoL), and Pre-specified biomarkers (N-terminal B-type natriuretic peptide
(NT-ProBNP), Tissue growth factor-B B-type natriuretic peptide BNP, and Profibrotic markers)